2016 June | The Journal of Targeted Therapies in Cancer

From the Chairman: Moving Forward With Bold Innovation

July 14, 2016

Clinical Articles

As I write this, the 2016 ASCO conference has just concluded in Chicago. And, as is typical with this event, the amount and level of groundbreaking research and information presented at this year's conference is nothing less than staggering in its scope, innovation, and promise.

From the Editor: Is Cancer a Curable Disease?

July 14, 2016

Clinical Articles

After just returning from the 2016 American Society of Clinical Oncology meeting in Chicago, it was clear that there is a palpable excitement over recent progress in cancer research and therapeutic drug development.

Immune Checkpoint Blockade: A New Strategy for the Treatment of Breast Cancer

July 13, 2016

Clinical Articles

Breast cancer has traditionally not been viewed as immunogenic. There is now a growing body of evidence that immune infiltration has a prognostic role in al breast cancer subtypes, and predicts improved clinical outcome in triple-negative and human epidermal growth factor receptor 2-positive tumors.